• 
  Fatima Lakis, Pauline Barraja, Gilles Freiss, Peter Coopman, Fadi Abdel Sater, et al.. Role of proteins involved in epithelial integrity and polarity, regulated by (de)phosphorylation by Syk or PTPN13, in mammary tumour invasion. Annual Congress of the European Association for Cancer Research (EACR 2024), Jun 2024, Rotterdam, Netherlands. pp.351. ⟨hal-04794364⟩
• 
  Anne Caignard, Mary Poupot-Marsan, Virginie Lafont, Daniela Wesch, Chiara Porta. Editorial: New insights into innate immune cell-based immunotherapies in cancer. Frontiers in Immunology, 2024, 15, pp.2. ⟨10.3389/fimmu.2024.1401665⟩. ⟨hal-04795211⟩
• 
  Soledad Marsile-Medun, Manon Souchard, Daouda Abba Moussa, Valerie Lorin, Hugo Mouquet, et al.. Enhanced Fc Receptor expression and distinct immunomodulatory properties of neutrophils during HIV-1 infection and therapy. 2024. ⟨hal-04788445⟩
• 
  Carl Mathis Wild, Fabian Garrido, Christian Dannecker, Melitta Köpke, Marie-Christine Chateau, et al.. Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma. Cancers, 2023, 15 (20), pp.4952. ⟨10.3390/cancers15204952⟩. ⟨hal-04785108⟩
• 
  Iulian Ban, Alice Chabert, Thomas Guignard, Jacques Puechberty, Simon Cabello-Aguilar, et al.. Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing. Frontiers in Oncology, 2024, 14, pp.7. ⟨10.3389/fonc.2024.1355715⟩. ⟨hal-04785069⟩
• 
  Quentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, Cesar Lefevbre, Sarah Cavaillon, et al.. Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study. Cancers, 2024, 16 (5), pp.992. ⟨10.3390/cancers16050992⟩. ⟨hal-04783863⟩
• 
  Nour Sfeir, Marilyn Kajdan, Stéphan Jalaguier, Sandrine Bonnet, Catherine Teyssier, et al.. RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells. Molecular Oncology, 2024, 18 (6), pp.1510-1530. ⟨10.1002/1878-0261.13626⟩. ⟨hal-04782374⟩
• 
  Sarah Dandou, Kriti Amin, Véronique D’hondt, Jérôme Solassol, Olivier Dereure, et al.. Improved prediction of the response duration to MAPK inhibitors in patients with advanced melanoma using baseline genomic data and machine learning algorithms. 2023. ⟨hal-04781510⟩
• 
  Simon Baldacci, Benjamin Besse, Virginie Avrillon, Bertrand Mennecier, Julien Mazieres, et al.. Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. European Journal of Cancer, 2022, 166, pp.51-59. ⟨10.1016/j.ejca.2022.01.018⟩. ⟨hal-04728569⟩
• 
  Chikako Kanno Honda, Sasagu Kurozumi, Takaaki Fujii, Didier Pourquier, Lakhdar Khellaf, et al.. Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8 + T-cell infiltration in breast cancer. Theranostics, 2024, 14 (5), pp.1873-1885. ⟨10.7150/thno.90627⟩. ⟨hal-04780070⟩
• 
  Jean-Pierre Borg, Jacques Colinge, Patrice Ravel. Modular response analysis reformulated as a multilinear regression problem. Bioinformatics, 2023, 39 (4), ⟨10.1093/bioinformatics/btad166⟩. ⟨hal-04779962⟩
• 
  Miriam Rodríguez-Vázquez, Jennifer Falconi, Lisa Heron-Milhavet, Patrice Lassus, Charles Géminard, et al.. Fat body glycolysis defects inhibit mTOR and promote distant muscle disorganization through TNF-α/egr and ImpL2 signaling in Drosophila larvae. EMBO Reports, 2024, 25 (10), pp.4410 - 4432. ⟨10.1038/s44319-024-00241-3⟩. ⟨hal-04778451⟩
• 
  Anis Krache, Charlotte Fontan, Carine Pestourie, Manuel Bardiès, Yann Bouvet, et al.. Preclinical Pharmacokinetics and Dosimetry of an 89Zr Labelled Anti-PDL1 in an Orthotopic Lung Cancer Murine Model. Frontiers in Medicine, 2022, 8, pp.741855. ⟨10.3389/fmed.2021.741855⟩. ⟨hal-04777861⟩
• 
  Loïs Coënon, Emilie Rigal, Hortense Courot, Caroline Multrier, Sara Zemiti, et al.. Generation of non-genetically modified, CAR-like, NK cells. Journal for Immunotherapy of Cancer, 2024, 12 (7), pp.e009070. ⟨10.1136/jitc-2024-009070⟩. ⟨hal-04777713⟩
• 
  Sylvain Lehmann, Jérôme Vialaret, Audrey Gabelle, Luc Bauchet, Jean-Philippe Villemin, et al.. Enabling Population Protein Dynamics Through Bayesian Modeling. Bioinformatics, 2024, 40 (8), pp.btae484. ⟨10.1093/bioinformatics/btae484⟩. ⟨hal-04776981⟩
• 
  Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
• 
  J. Guigay, C. Ortholan, D. Vansteene, D. Cupissol, C. Even, et al.. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial. The Lancet. Healthy longevity, 2024, 5 (3), pp.e182--e193. ⟨10.1016/s2666-7568(23)00284-2⟩. ⟨hal-04661312⟩
• 
  Flora Gouzerh, Laurent Dormont, Bruno Buatois, Maxime Hervé, Maicol Mancini, et al.. Partial role of volatile organic compounds in behavioural responses of mice to bedding from cancer-affected congeners. Biology Open, 2024, 13 (10), pp.bio060324. ⟨10.1242/bio.060324⟩. ⟨hal-04772179⟩
• 
  Francois Gouin, Audrey Michot, Mehrdad Jafari, Charles Honoré, Jean Camille Mattei, et al.. Improved metastatic-free survival after systematic re-excision following complete macroscopic unplanned excision of limb or trunk soft tissue sarcoma. Cancers, 2024, 16 (7), pp.1365. ⟨10.3390/cancers16071365⟩. ⟨hal-04653665⟩
• 
  Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, Nesrine Mabrouk, Gauthier Gadouas, et al.. Cytokine profile of anti-spike CD4+T cells predicts humoral and CD8+T cell responses after anti-SARS-CoV-2 mRNA vaccination. iScience, 2024, 27 (8), ⟨10.1016/j.isci.2024.110441⟩. ⟨hal-04770811⟩

1 147

1 091